// OVERVIEW
Biopharmaceutical company acquiring Vega Therapeutics for up to $2B ($1.25B upfront).
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
m_and_a·Axios Pro Rata·JUNE 8, 2026
“Incyte agreed to acquire Vega Therapeutics… for up to $2b ($1.25b upfront) from VC-backed Star Therapeutics.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.